Transglutaminase type 2 affects cell migration through post-translational modification of platelet-derived growth factor-BB.

scientific article published on 16 September 2016

Transglutaminase type 2 affects cell migration through post-translational modification of platelet-derived growth factor-BB. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S00726-016-2331-Z
P698PubMed publication ID27633721

P50authorClaudio TabolacciQ60731103
P2093author name stringFrancesco Facchiano
Stefania Rossi
Angelo M Facchiano
Antonio Facchiano
Daniela D'Arcangelo
Cinzia Senatore
Martina Cordella
P2860cites workTissue transglutaminase facilitates the polymerization of insulin-like growth factor-binding protein-1 (IGFBP-1) and leads to loss of IGFBP-1's ability to inhibit insulin-like growth factor-I-stimulated protein synthesisQ40835429
Chemokines involved in the early inflammatory response and in pro-tumoral activity in asbestos-exposed workers from an Italian coastal area with territorial clusters of pleural malignant mesothelioma.Q40855818
Expression of tissue transglutaminase in Balb-C 3T3 fibroblasts: effects on cellular morphology and adhesionQ42816111
BAMM: a preliminary bibliometric analysis on melanoma manuscripts.Q45722540
A novel actin label: a fluorescent probe at glutamine-41 and its consequencesQ46104760
Glioblastoma and cerebral microvascular endothelial cell migration in response to tumor-associated growth factorsQ48303307
Neuropilin-1 signaling through p130Cas tyrosine phosphorylation is essential for growth factor-dependent migration of glioma and endothelial cellsQ24337623
Cell migration: integrating signals from front to backQ27860670
Transglutaminase 2 has opposing roles in the regulation of cellular functions as well as cell growth and deathQ28069852
Cancer metastases: challenges and opportunitiesQ28088755
Clinical proteomics: Written in bloodQ28213537
Physiological, pathological, and structural implications of non-enzymatic protein-protein interactions of the multifunctional human transglutaminase 2Q28261578
Differential denaturation of serum proteome reveals a significant amount of hidden information in complex mixtures of proteinsQ28488743
Role of platelet-derived growth factors in physiology and medicineQ29615222
Collective cell migration in morphogenesis, regeneration and cancerQ29616634
Platelet-derived growth factor receptor/platelet-derived growth factor (PDGFR/PDGF) system is a prognostic and treatment response biomarker with multifarious therapeutic targets in cancersQ30250273
Homology modelling of the human eukaryotic initiation factor 5A (eIF-5A).Q30329258
Platelet-derived growth factor BB mediates the tropism of human mesenchymal stem cells for malignant gliomasQ33609232
Characterization of distinct sub-cellular location of transglutaminase type II: changes in intracellular distribution in physiological and pathological statesQ34517980
Extracellular TG2: emerging functions and regulationQ35587161
Transglutaminase and polyamination of tubulin: posttranslational modification for stabilizing axonal microtubulesQ36768195
Early stage cancer cell invasion: signaling, biomarkers and therapeutic targetingQ37175703
TG2, a novel extracellular protein with multiple functionsQ37912042
Transglutaminases: key regulators of cancer metastasis.Q37981102
Multifarious functions of PDGFs and PDGFRs in tumor growth and metastasisQ38115027
Vemurafenib-Induced Disseminated Intravascular Coagulation in Metastatic Melanoma.Q38207979
Chemokines in cancer development and progression and their potential as targeting molecules for cancer treatmentQ38223355
Metastasis review: from bench to bedsideQ38237985
PDGF receptors in tumor biology: prognostic and predictive potentialQ38241990
Theoretical model of the three-dimensional structure of a sugar-binding protein from Pyrococcus horikoshii: structural analysis and sugar-binding simulationsQ38343706
Platelet-derived growth factor (PDGF) signalling in cancer: rapidly emerging signalling landscapeQ38543837
Force Matters: Biomechanical Regulation of Cell Invasion and Migration in DiseaseQ38801418
Tissue transglutaminase activity protects from cutaneous melanoma metastatic dissemination: an in vivo studyQ39316877
PDGF-D/PDGF-ββ receptor-regulated chemotaxis of malignant mesothelioma cellsQ39380409
Active Sequences Collection (ASC) database: a new tool to assign functions to protein sequencesQ39790308
Endothelial and nonendothelial sources of PDGF-B regulate pericyte recruitment and influence vascular pattern formation in tumorsQ39961300
P433issue3
P304page(s)473-481
P577publication date2016-09-16
P1433published inAmino AcidsQ15757015
P1476titleTransglutaminase type 2 affects cell migration through post-translational modification of platelet-derived growth factor-BB.
P478volume49

Reverse relations

cites work (P2860)
Q60928165TNF-alpha and metalloproteases as key players in melanoma cells aggressiveness
Q64249805The Role of Tissue Transglutaminase in Cancer Cell Initiation, Survival and Progression